2023. Exploring the Potential of Drug Repurposing: Detection of Cystic Fibrosis Transmembrane Conductance Regulator as a Biomarker in Breast Cancer Patients. Precision Medicine Communications. 3, 1 (Jun. 2023), 11–26. DOI:https://doi.org/10.55627/pmc.003.01.0300.